G85767HW

Summary
GlyTouCan ID
G85767HW
IUPAC Condensed
GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-4)][Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc(b1-
Motifs
N-Glycan complex N-acetyllactosamine Type 2 LN
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1827.68
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
MGAT3 UDP-GlcNAc
G27919IH
Asn-X
G85767HW
Asn-X
KEGG BRITE Database
KEGG ID
GALAXY
Glucose Units
ODS
18.7
Amide
6.6
Degrading Enzymes
Displaying all 3 entries
Enzyme Substrate Product
α-Fucosidase
G85767HW
G11535IB
β-Galactosidase
G85767HW
G30159WR
β-HexNAcase
G85767HW
G61334IA
Glycans containing this structure in GALAXY
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:b-dglc-HEX-1:5
8s:n-acetyl
9b:b-dglc-HEX-1:5
10s:n-acetyl
11b:a-dman-HEX-1:5
12b:b-dglc-HEX-1:5
13s:n-acetyl
14b:b-dgal-HEX-1:5
15b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7d(2+1)8n
8:5o(4+1)9d
9:9d(2+1)10n
10:5o(6+1)11d
11:11o(2+1)12d
12:12d(2+1)13n
13:12o(4+1)14d
14:1o(6+1)15d
WURCS
WURCS=2.0/5,10,9/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a2112h-1b_1-5][a1221m-1a_1-5]/1-1-2-3-1-1-3-1-4-5/a4-b1_a6-j1_b4-c1_c3-d1_c4-f1_c6-g1_d2-e1_g2-h1_h4-i1
Literature
Displaying entries 1 - 10 of 16 in total
PubMed ID Title First Author Publication Date Source
33242084 Post-natal developmental changes in the composition of the rat neocortical N-glycome Klarić Thomas S 2021-06-03
  • GlyGen
33383989 Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis Wongtrakul-Kish K 2021 Feb 5
  • GlyGen
33255418 A Potential Serum N-glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis Higashi M 2020 Nov 24
  • GlyGen
30674035 Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis Costa J 2019 Jan 23
  • GlyGen
24680513 Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species Adamczyk B 2014 May 07
  • GlyGen
  • PubChem
24090084 Site-Specific Glycan-Peptide Analysis for Determination of N-Glycoproteome Heterogeneity Parker BL 2013 Dec 6
  • GlyGen
  • PubChem
14693911 Site-specific N-glycosylation of chicken serum IgG Suzuki Noriko 2004-03
  • GlyGen
12652077 Structural studies on IgG oligosaccharides of patients with primary Sjogren's syndrome Kuroda Y 2002 Jan
  • GlyGen
  • PubChem
10406848 Glycosylation of a CNS-specific extracellular matrix glycoprotein, tenascin-R, is dominated by O-linked sialylated glycans and 'brain-type' neutral N-glycans Zamze S 1999 Aug
  • GlyGen
  • PubChem
7785764 Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography Nakagawa H 1995 Mar 20
  • GlyGen

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.3.0

Last updated: August 4, 2025